A carregar...
Molecular targets in melanoma: time for `ethnic personalization'
Worldwide, the incidence of melanoma continues to rise. Although not the most common cutaneous malignancy, it is the most lethal. Until recently, while other oncologic patients benefited from the nuances of targeted therapy, those afflicted with melanoma lacked that option. In 2011, the US FDA appro...
Na minha lista:
| Publicado no: | Expert Rev Anticancer Ther |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4877024/ https://ncbi.nlm.nih.gov/pubmed/22594895 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/era.12.39 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|